There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Structure of 1294001-16-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size

Price

VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock

{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

{[ item.pr_size ]}
{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

Quality Control of [ 1294001-16-3 ] Purity: 95% SDS Specification

COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

1-2 Day Shipping
High Quality
Technical Support

Product Details of [ 1294001-16-3 ]

CAS No. :	1294001-16-3
Formula :	C₇H₆F₃N₃OS
M.W :	237.20
SMILES Code :	FC(C1=CN2C(SC(COC)=N2)=N1)(F)F
English Name :	2-(Methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazole
MDL No. :	MFCD30803541

Safety of [ 1294001-16-3 ]

GHS Pictogram:
Signal Word:
Hazard Statements:
Precautionary Statements:
Class:
UN#:
Packing Group:

Application In Synthesis of [ 1294001-16-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 1294001-16-3 ]

[ 1294001-16-3 ] Synthesis Path-Downstream 1~14

1
[ 15884-86-3 ]
[ 431-35-6 ]
[ 1294001-16-3 ]

Yield	Reaction Conditions	Operation in experiment
47%	In 1,2-dimethoxyethane at 20 - 80℃; for 24h;	2.2 2.2 Synthesis of 2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1 - bJ[1 ,3,4]thiadiazole a28.Bromotrifluoroacetone (478 g, 1.05 eq) is added on a suspension of 5- (methoxymethyl)-1 ,3,4-thiadiazol-2-amine a25 (346 g, 1 eq) in 1 ,2-dimethoxyethane (6 I) at 20°C. The reaction mixture is heated to 80°C until maximum conversion (<24 h). Water (4 I) is added to the reaction mixture at 32°C and the expected compound crystallized out of the reaction mixture. The crystalline suspension is cooled to 10°C to complete the crystallization process, filtered and the crystalline precipitate is washed with water (1 ,5 I) to afford 266 g of pure 2-(methoxymethyl)-6- (trifluoromethyl)imidazo[2, 1 -b][1 ,3,4]thiadiazole a28.Yield: 47 %.LC-MS (MH+): 238.
47%	In 1,2-dimethoxyethane at 20 - 80℃; for 24h;	1.1 1.1 Synthesis of 2-(methoxymethyl)-6-(trifluoromethyl)imiclazo[2,1-b][1 ,3,4]thia- diazole a2.Bromotrifluoroacetone (478 g, 2.5 mol, 1.05 eq) is added on a suspension of 5- (methoxymethyl)-1 ,3,4-thiadiazol-2-amine a1 (346 g, 2.4 mol, 1 eq) in 1 ,2- dimethoxyethane (6 I) at 20°C. The reaction mixture is heated to 80°C until maximum conversion (<24 h). Water (4 I) is added to the reaction mixture at 32°C and the expected compound crystallized out of the reaction mixture. The crystalline suspension is cooled to 10°C to complete the crystallization process, filtered and the crystalline precipitate is washed with water (1 ,5 I) to afford 266 g of pure 2-(methoxymethyl)-6- (trifluoromethyl)imidazo[2,1 -b][1 ,3,4]thiadiazole a2.Yield: 47 %.LC-MS (MH+): 238.
47%	In 1,2-dimethoxyethane; water at 80℃; for 24h;	1.1 1.1 Synthesis of 2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazole VIII. 3-Bromo-1,1,1-trifluoroacetone (CAS: 431-35-6, 478 g, 2.5 mol, 1.05 eq) is added on a suspension of 5-(methoxymethyl)-1,3,4-thiadiazol-2-amine (CAS: 15884-86-33, 46 g, 2.4 mol, 1 eq) in 1,2-dimethoxyethane (6 I) at 20°C. The reaction mixture is heated to 80°C until maximum conversion (<24 h). Water (4 I) is added to the reaction mixture at 32°C and the expected compound crystallized out of the reaction mixture. The crystalline suspension is cooled to 10°C to complete the crystallization process, filtered and the crystalline precipitate is washed with water (1,5 I) to afford 266 g of pure 2- (methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazole VIII. Yield: 47 %. LC-MS (MH+): 238.

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2011/47860, 2011, A1 Location in patent: Page/Page column 26.
[2]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1 Location in patent: Page/Page column 28.
[3]Current Patent Assignee: UCB BIOPHARMA - WO2019/215062, 2019, A1 Location in patent: Page/Page column 34.

2
[ 1294001-16-3 ]
[ 1294001-37-8 ]
[ 1294000-61-5 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 2 steps 1: zinc(II) chloride / 1,4-dioxane / 216 h / 80 - 90 °C / Reflux 2: Chiralpak AS-V / n-heptane; ethanol / 30 °C / Resolution of racemate

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2011/47860, 2011, A1.

3
[ 1294001-05-0 ]
[ 1294001-16-3 ]
[ 1294000-59-1 ]

Yield	Reaction Conditions	Operation in experiment
74%	With zinc(II) chloride In 1,4-dioxane at 80 - 90℃; for 216h; Reflux;	2.3 2.3 Synthesis of 4-(2-chloro-2,2-difluoroethyl)-1-[2-(methoxymethyl)-6-(trifluoro- methyl)imidazo[2,1 -b][1 ,3,4]thiadiazol-5-yl]methyl}pyrrolidin-2-one 4 and enantiomers 5 and 6.To a hot solution (80°C) of ZnCl2 (0.23 g, 1.69 mmol, 10 mol%) and 2- (methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1-b][1 ,3,4]thiadiazole a28 (4 g, 16.96 mmol) in dioxane (200 ml) is added a solution of 4-(2-chloro-2,2-difluoroethyl)-1- (chloromethyl)pyrrolidin-2-one a18 in dioxane (5 ml). The reaction mixture is heated at 85°C for 5 days, then a further 2 g of pyrrolidinone a18 is added in one portion and the reaction mixture is kept under agitation at 90°C for 1 day. A further addition of pyrrolidinone a18 (2 g) in order to insure complete conversion of compound a28 and further heating of the reaction mixture at reflux for 3 days increased significatively the conversion of imidazo[2,1 -b][1 ,3,4]thiadiazole a28. After cooling and hydrolysis (250 ml of water), the crude mixture is extracted by CH2CI2 (2 x 250ml). The cumulated organic layers are dried over MgS04, filtered and condensed under reduced pressure. The residue is purified over silicagel (eluent: Ch^C^/MeOH/ h^OH 99/1/0.1) to afford 4-(2-chloro-2,2-difluoroethyl)-1 -[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1 - b][1 ,3,4]thiadiazol-5-yl]methyl}pyrrolidin-2-one 4.Yield: 74 %.LC- S (MH+): 433/435.

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2011/47860, 2011, A1 Location in patent: Page/Page column 27.

4
[ 1294001-16-3 ]
[ 1294001-33-4 ]
[ 1294000-82-0 ]

Yield	Reaction Conditions	Operation in experiment
30%	With zinc(II) chloride In 1,4-dioxane at 90℃; for 120h;	8.3 8.3 Synthesis of (4R)-4-(2-chloro-2,2-dif luoroethyl)-1 -[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1 -b][1 ,3,4]thiadiazol-5-yl](2H2)methyl}pyrrolidin-2-one 32.(4R)-4-(2-chloro-2,2-difluoroethyl)-1 -[chloro(2H2)methyl]pyrrolidin-2-one §46 is redissolved in dry dioxane (3.4 ml) and is added at 90°C to a mixture of 2- (methoxymethyl)-6-(trifluoromethyl)imidazo[2,1 -b][1 ,3,4]thiadiazole a28 (0.85 g, 1.0 eq mol) and zinc chloride (0.27 g, 0.55 eq mol) in dioxane (5 ml). The reaction mixture is stirred for 5 days at this temperature. After reaction completion and extractive work-up, the product is purified by preparative reverse phase chromatography (eluent: CH3CN/H2O/NH4OH 30/70/0.1 ) followed by a chromatography over normal phase (eluant: CH2CI2/EtOH/NH4OH 99.5/0.5/0.05) to afford 0.46 g of (4R)-4-(2-chloro-2,2- difluoroethyl)-1 -[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1 -b][1 ,3,4]thiadiazol-5- yl](2H2)methyl}pyrrolidin-2-one 32.Yield: 30 %.LC-MS (MH+): 435/437.

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2011/47860, 2011, A1 Location in patent: Page/Page column 37.

5
[ 50-00-0 ]
[ 1294001-16-3 ]
[ 1403586-59-3 ]

Yield	Reaction Conditions	Operation in experiment
58%	Stage #1: formaldehyd; 2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazole With hydrogenchloride In sulfolane; water at 110℃; Stage #2: With water In sulfolane at 50℃; for 2h;	1.2 1.2 Synthesis of [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1 ,3,4]thiadiazol -5-yl]methanol a3.2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1 ,3,4]thiadiazole a2 (10 g, 42.16 mmol, 1 eq), formaldehyde (16 g, 421.6 mmol, 10 eq) and hydrochloric acid (37 %,8.2 ml, 2 eq) are diluted in sulfolane (250 ml). The reaction mixture is heated at 110°C overnight. Water (500 ml) is added and the mixture is heated at 50°C for 2h. The solvent is then removed under reduced pressure. The residue is purified by chromatography over silicagel (gradient; eluent: Ch^C^/MeOH/NI-^OH from 100/0/0 to 99/1/0.1 ) to afford 6.5 g of [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1 ,3,4]thiadiazol-5- yljmethanol a3 as a yellow solid.Yield: 58 %.LC-MS (MH+): 268.
58%	With hydrogenchloride In sulfolane; water at 110℃;	1.2 1.2 Synthesis of [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol -5-yl]methanol IX. 2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazole VIII (10 g, 42.16 mmol, 1 eq), formaldehyde (16 g, 421.6 mmol, 10 eq) and hydrochloric acid (37 %, 8.2 ml, 2 eq) are diluted in sulfolane (250 ml). The reaction mixture is heated at 1 10°C overnight. Water (500 ml) is added and the mixture is heated at 50°C for 2h. The solvent is then removed under reduced pressure. The residue is purified by chromatography over silicagel (gradient; eluent: ChC/MeOH/NhOH from 100/0/0 to 99/1/0.1) to afford 6.5 g of [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5- yl]methanol IX as a yellow solid. Yield: 58 %. LC-MS (MH+): 268.
41%	With hydrogenchloride In 1,4-dioxane; water at 100℃; for 18h; Sealed tube;	1.4 1.4 Synthesis of [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1- b][1 ,3,4]thiadiazol-5-yl]methanol V In a sealed tube, 2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1-b][1 ,3,4]thiadiazole IV (CAS: 1294001-16-3, patent application WO 2012/1431 17, 1 eq., 2.0 g, 8.4 mmol), paraformaldehyde (6.0 eq., 1 .52 g, 50.6 mmol) and an aqueous solution of hydrochloric acid (2N) (1 .0 equiv., 4.2 ml_, 8.4 mmol) were mixed in 1 ,4-dioxane (4 ml_). The mixture was stirred at 100°C for 18 h and the reaction was checked by LC/MS. The crude mixture was cooled to RT and an aqueous saturated solution of NaHC03 was added until pH=6-7. The aqueous layer was extracted with ethyl acetate (three times) and the combined organic layers were washed with brine, dried over MgSC , filtered and evaporated to dryness. The crude was purified by flash chromatography Biotage Isolera Four (100 g KP-SNAP silica gel column in a gradient of 0% to 10% methanol in dichloromethane over 15 CV) to give [2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2, 1 - b][1 ,3,4]thiadiazol-5-yl]methanol (1.06 g, 3.5 mmol) V as a beige solid. The compound was used directly in the next step without any further purification. Yield: 41 %LC/MS: [M+H]+ = 268.2 1H NMR (400 MHz, CDCI3): δ 5.04 (d, J = 5.2 Hz, 2H), 4.77 (s, 2H), 3.53 (s, 3H), 2.32 (t, J = 6.3 Hz, 1 H).

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1 Location in patent: Page/Page column 28.
[2]Current Patent Assignee: UCB BIOPHARMA - WO2019/215062, 2019, A1 Location in patent: Page/Page column 35.
[3]Current Patent Assignee: UCB BIOPHARMA - WO2019/11770, 2019, A1 Location in patent: Page/Page column 22; 23; 24.

6
[ 1294001-16-3 ]
[ 1403739-22-9 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 2 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: toluene-4-sulfonic acid / toluene / 110 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

7
[ 1294001-16-3 ]
[ 1403739-22-9 ]
[ 1403739-22-9 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 3 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: toluene-4-sulfonic acid / toluene / 110 °C 3.1: Chiralpak IC / isopropyl alcohol; n-heptane / 30 °C / Resolution of racemate

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

8
[ 1294001-16-3 ]
[ 1403586-70-8 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 2 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C
	Multi-step reaction with 2 steps 1: hydrogenchloride / water; sulfolane / 110 °C 2: N-ethyl-N,N-diisopropylamine; sodium azide; methanesulfonyl chloride / N,N-dimethyl-formamide; dichloromethane / 0 - 20 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.
[2]Current Patent Assignee: UCB BIOPHARMA - WO2019/215062, 2019, A1.

9
[ 1294001-16-3 ]
[ 1403586-73-1 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 3 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C
	Multi-step reaction with 3 steps 1: hydrogenchloride / water; sulfolane / 110 °C 2: N-ethyl-N,N-diisopropylamine; sodium azide; methanesulfonyl chloride / N,N-dimethyl-formamide; dichloromethane / 0 - 20 °C 3: triphenylphosphine / water; tetrahydrofuran / 60 h / 20 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.
[2]Current Patent Assignee: UCB BIOPHARMA - WO2019/215062, 2019, A1.

10
[ 1294001-16-3 ]
[ 1403739-45-6 ]
[ 1403739-48-9 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 6 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C 4.1: sodium carbonate / N,N-dimethyl-formamide / 20 °C 5.1: N,N-dimethyl-formamide 6.1: potassium <i>tert</i>-butylate / N,N-dimethyl-formamide / 4 h / 75 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

11
[ 1294001-16-3 ]
[ 1403739-46-7 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 4 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C 4.1: sodium carbonate / N,N-dimethyl-formamide / 20 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

12
[ 1294001-16-3 ]
[ 1403739-47-8 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 5 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C 4.1: sodium carbonate / N,N-dimethyl-formamide / 20 °C 5.1: N,N-dimethyl-formamide

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

13
[ 1294001-16-3 ]
[ 1403739-29-6 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 7 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C 4.1: sodium carbonate / N,N-dimethyl-formamide / 20 °C 5.1: N,N-dimethyl-formamide 6.1: potassium <i>tert</i>-butylate / N,N-dimethyl-formamide / 4 h / 75 °C 7.1: hydrogenchloride / water / 168 h / 80 °C

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

14
[ 1294001-16-3 ]
[ 1403739-29-6 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 8 steps 1.1: hydrogenchloride / sulfolane; water / 110 °C 1.2: 2 h / 50 °C 2.1: N-ethyl-N,N-diisopropylamine; methanesulfonyl chloride; sodium azide / dichloromethane; N,N-dimethyl-formamide / 0 - 20 °C 3.1: triphenylphosphine; water / tetrahydrofuran / 60 h / 20 °C 4.1: sodium carbonate / N,N-dimethyl-formamide / 20 °C 5.1: N,N-dimethyl-formamide 6.1: potassium <i>tert</i>-butylate / N,N-dimethyl-formamide / 4 h / 75 °C 7.1: hydrogenchloride / water / 168 h / 80 °C 8.1: Chiralpak AS-V / isopropyl alcohol; n-heptane / 30 °C / Resolution of racemate

References: [1]Current Patent Assignee: UCB BIOPHARMA - WO2012/143117, 2012, A1.

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

{[proInfo.proName]}

CAS No.: 1294001-16-3

{[proInfo.proName]}

CAS No.: 1294001-16-3

Alternative Products

Product Details of [ 1294001-16-3 ]

Safety of [ 1294001-16-3 ]

Application In Synthesis of [ 1294001-16-3 ]

[ 1294001-16-3 ] Synthesis Path-Downstream 1~14

Related Products

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator